One of the most influential marijuana breeders in the world has sued a cannabis company, alleging that he lost his job there due to the fact that he suffers from Parkinson’s Disease Illness and certain adaptations are required.
Christopher Lynch filed the lawsuit against Node Labs Inc. in San Francisco court on Monday.
The complaint details Lynch’s diagnosis of Parkinson’s disease in 2014, and his dealings with Node Labs.
In 2017, Lynch “began working on the genetic development and breeding of cannabis plants including, but not limited to ‘C. Agreement with Node Labs in 2019 to sell Compound IP LLC assets.
But by 2020, the relationship between Lynch and the company was deteriorating. According to the complaint, the defendants “were actively frustrating the purpose of the original contract by refusing to provide it [Lynch] With sales accounting on its basis [his] on the basis of compensation.
“additional, [Node Labs] He did not pay [Lynch] His sales reward. The defendants continued to thwart the purpose and purpose of the original contract throughout the remainder of his employment and beyond,” the complaint says.
“Throughout the Plaintiff’s employment, the Defendants used the Plaintiff’s position in the genetic industry to promote the NODE and COMPOUND brand. Although the Plaintiff was not required by its employment agreement, the Defendants required the Plaintiff to appear, participate in interviews, and market the brand using its name And his example,” the complaint continues.
In the lawsuit, Lynch alleged that in May 2021, Lauren Avenius, CEO of Node Labs, attempted to “minimize [Lynch’s] Significance and future role with the company by telling a major investor that the plaintiff has been diagnosed with Parkinson’s disease.”
After months of alleged disagreements between the two sides, the complaint says Lynch was fired from his position in December, a week after filing a “complaint against [Node Labs] With the Department of Fair Employment and Housing.”
“on time, [Lynch] He was on medical leave and [Node Labs] have closed [him] outside the company’s email system,” according to the complaint.
Lynch, who has bred some of the most popular cannabis strains available and collaborated with brands and celebrities, Summed up last week by Forbes.
He’s the man behind some of the most popular strains on the market today including Pink Certz, Apples & Bananas, Khalifa Mint, Blueberry Banana, Fish Scale, Eye Candy, and more. The chemistry of new flavors using rare, hard-to-find genetics is bread and knoll. Lynch strain Pink Sirtz It won the 2022 Breed of the Year Award from High Times. The previous year, High Times had considered Lynch one of the 100 most influential people in cannabis. Pink Certz also won first place in the 2022 Transbay Challenge III.” Forbes He said.
“His success has been difficult. Lynch was diagnosed with early-onset Parkinson’s disease in 2014 after undergoing brain surgery to remove a cerebellar cyst located inside the back of his head.”
Life is precious, be grateful for what you have. Lynch said Forbes. “Your life can change overnight. Don’t wait to pursue your dreams and goals.”
The profile details how Lynch got into cannabis after he “dropped out of high school his sophomore year and moved to Amsterdam in 2004 and Rotterdam in 2005.”
During his time in Holland, Lynch immersed himself in the cannabis culture and learned a tremendous amount. He brought this knowledge back to Portland, Oregon, where he began his career growing medical marijuana.
